Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05784922 · ClinicalTrials.gov registry record
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
A clinical trial of Lung Cancer and Smoking Behaviors, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT05784922 is a study of Lung Cancer and Smoking Behaviors that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 2,000 participants, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (115% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05784922, a study of Lung Cancer and Smoking Behaviors, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to promote lung cancer screening (LCS) uptake among Hispanic current and former smokers. The main questions it aims to answer are: * What barriers do current and former Hispanic smokers face in the identification and documentation of their smoking status? * How can digital delivery of an educational video promote LCS uptake among current and former Hispanic smokers? Participants will receive an educational video about lung cancer screening and complete brief, self-reported surveys afterwards.
Conditions Studied
Interventions
- OTHER Educational Lung Cancer Screening (LCS) Video
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2023-02-03 |
| Est. Completion | 2028-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05784922
The ClinicalTrials.gov registry entry for NCT05784922 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (115% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Educational Lung Cancer Screening (LCS) Video is the first listed.
NCT05784922 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05784922 about?
NCT05784922 is a clinical study titled "Health Opportunities and Promoters of Equitable Screening for Lung Cancer". The goal of this clinical trial is to promote lung cancer screening (LCS) uptake among Hispanic current and former smokers. The main questions it aims to answer are: * What barriers do current and former Hispanic smokers face in the identification and documentation of their smoking status? * How ca...
What is the current status of trial NCT05784922?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2023-02-03. Estimated completion is 2028-01-31.
What conditions does trial NCT05784922 study?
This clinical trial studies the following conditions: Lung Cancer, Smoking Behaviors, Diagnosis.
What interventions are being tested in trial NCT05784922?
The interventions under investigation include: Educational Lung Cancer Screening (LCS) Video (OTHER).
Who is sponsoring clinical trial NCT05784922?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05784922 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.